Showing results (951-960 of 991) with videos related to
Sort By:
Pageof 100
Assay and Drug Development Technologies|March 1, 2021
Dual Drug Loaded Bilayer Hydrogel Coated with Citric Acid for the Treatment of Dry Mouth SyndromeRamya Devi Durai, Jaya Nallakkannu, Kalaimagal Rajaraman, et al.Assay and Drug Development Technologies|November 12, 2021
Activities of Nanoparticles Against Fluconazole-Resistant Candida parapsilosis in Clinical IsolatesEnsieh Lotfali, Reza Ghasemi, Azam Fattahi, et al.Assay and Drug Development Technologies|November 2, 2012
Metabolically functional hepatocyte-like cells from human umbilical cord lining epithelial cellsHan Hui Cheong, Jeyakumar Masilamani, Chun Yong Eric Chan, et al.Assay and Drug Development Technologies|January 22, 2014
A micropatterned hepatocyte coculture model for assessment of liver toxicity using high-content imaging analysisO Joseph Trask, Amanda Moore, Edward L LeCluyseAssay and Drug Development Technologies|May 17, 2014
Evaluation of impermeant, DNA-binding dye fluorescence as a real-time readout of eukaryotic cell toxicity in a high throughput screening formatLucius Chiaraviglio, James E KirbyAssay and Drug Development Technologies|May 17, 2014
A phenotypic high throughput screening assay for the identification of pharmacoperones for the gonadotropin releasing hormone receptorP Michael Conn, Emery Smith, Timothy Spicer, et al.Assay and Drug Development Technologies|June 7, 2014
The development of automated patch clamp assays for canonical transient receptor potential channels TRPC3, 6, and 7Mark McPate, Gurdip Bhalay, Martin Beckett, et al.Assay and Drug Development Technologies|July 4, 2012
Development of a high-throughput calcium flux assay for identification of all ligand types including positive, negative, and silent allosteric modulators for G protein-coupled receptorsDevin J Noblin, Robert L Bertekap, Neil T Burford, et al.Assay and Drug Development Technologies|August 16, 2018
High-Content Screening Campaign to Identify Compounds That Inhibit or Disrupt Androgen Receptor-Transcriptional Intermediary Factor 2 Protein-Protein Interactions for the Treatment of Prostate CancerAshley T Fancher, Yun Hua, Daniel P Camarco, et al.Assay and Drug Development Technologies|August 28, 2018
Know When You Don't Know: A Robust Deep Learning Approach in the Presence of Unknown PhenotypesOliver Dürr, Elvis Murina, Daniel Siegismund, et al.Pageof 100